CSD activates the trigeminal neurovascular system, and the trigeminal ganglion releases calcitonin gene-related peptides (CGRP), substance P, and other neuropeptides, causing meningeal vascular inflammation, and thus leading to migraine symptoms. Here, CALCA is linked to migraine disorder.